Valbenazine for Tardive Dyskinesia

What You Need to Know:

The use of valbenazine, a highly selective vesicular monoamine transporter 2 inhibitor, led to significant improvement of tardive dyskinesia in patients with underlying schizophrenia, schizoaffective disorder, or mood disorder.